Annual Alzheimer’s clinical trials pipeline report shows increased reason for optimism

An annual review of clinical trials for Alzheimer’s disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find a cure.

This post was originally published on this site

Skip The Dishes Referral Code

KeyLegal.ca - Consult a Lawyer Online in a variety of legal subjects